Mifepristone: from the public eye to the reproductive endocrinology and infertility specialists' eye

Alexander VM, Vinita M Alexander
F&S reports · 2024 · vol. 5(3) , pp. 250 · doi:10.1016/j.xfre.2024.08.008 · PMID:39381648 · PMC11457530
Other OA: gold publisher-OA-unknown
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-26 ⓘ

This review discusses the transition of mifepristone from public attention to its application in reproductive endocrinology and infertility, without providing specific findings on endometriosis or adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

infertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
pubmed
last seen: 2026-10-08T21:45:59.572399+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: publisher-OA-unknown · commercial use NOT OK · attribution required